AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE)
Launched by FRANCESCA CECCHI · Dec 10, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The ROOMMATE clinical trial is studying a new system designed to help adults recovering from subacute strokes improve their rehabilitation. This system includes multimedia monitors and special tools that offer games and exercises to support recovery right at the patient's bedside. The trial will take place in rehabilitation clinics in Italy and Romania, and it aims to see how well this technology, along with coaching for patients and their caregivers, can help improve daily functioning, satisfaction, and overall well-being.
To participate in this study, individuals must have experienced a stroke within the last three months and be willing to take part. Key factors for eligibility include being able to use the technology with some assistance, as well as not having severe vision, hearing, or cognitive impairments that would prevent effective use. If chosen for the trial, participants will use the ROOMMATE system alongside their usual care during their hospital stay, completely free of charge. This trial not only focuses on physical recovery but also looks at how patients feel about the treatment and its impact on their lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • outcome of ischemic or hemorrhagic stroke in subacute phase (\< 3 months after the event)
- • willingness to participate in the project, with informed consent signed by the subject or, when necessary, by the support administrator.
- Exclusion Criteria:
- • severe visual and/or auditory impairments that cannot be corrected
- • severe cognitive and/or speech impairments that interfere with the ability to use the HKK system and the SensoMode accessory independently and/or in the
- • absence of a caregiver who can assist the patient in using the system;
- • skin lesions that prevent wearing the inertial sensors;
- • presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale (SIC).
About Francesca Cecchi
Francesca Cecchi is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic interventions, Cecchi leads the design and implementation of clinical studies that adhere to the highest ethical and regulatory standards. Her expertise encompasses a wide range of therapeutic areas, and she collaborates closely with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of each trial. Francesca Cecchi's leadership and vision drive the pursuit of groundbreaking solutions in healthcare, fostering a collaborative environment that prioritizes scientific excellence and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Florence, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported